• 1
    Nielsen M., Hansen E., Gøzsche P. C. What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin reuptake inhibitors. Addiction 2012; 107: 9008.
  • 2
    Dikeos D. G., Soldatos C. R. The pharmacotherapy of insomnia: efficacy and rebound with hypnotic drugs. Prim Care Companion J Clin Psychiatry 2001; 4: 2732.
  • 3
    Heyman G. M. Addiction. A Disorder of Choice. Cambridge, MA: Harvard University Press; 2009.
  • 4
    Ashton C. H. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat 1991; 8: 1928.
  • 5
    Petursson H., Lader M. Dependence on Tranquillizers. Maudsley Monograph no. 28. Oxford: Oxford University Press; 1984.
  • 6
    Schatzberg A. F., Haddad P., Kaplan E. M., Lejoyeux M., Rosenbaum J. F., Young A. H. et al. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. J Clin Psychiatry 1997; 58: 510.
  • 7
    Tyrer P. Invited comment on Haddad and Quereshi. Acta Psychiatr Scand 2000; 102: 4689.
  • 8
    van Geffen E. C., Hugtenburg J. G., Heerdink E. R., van Hulten R. P., Egberts A. C. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. Eur J Clin Pharmacol 2005; 61: 3037.
  • 9
    Tint A., Haddad P. M., Anderson I. M. The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. J Psychopharmacol 2007; 22: 3302.
  • 10
    Loxley W. Benzodiazepine use and harms among police detainees in Australia. Trends Issues Crime Criminal Justice . 2007. Canberra, ACT: Australian Institute of Criminology (336).
  • 11
    NICE Clinical Guidelines 113–2, January. London; National Institute for Health and Clinical Excellence; 2011.